person · Reporting owner

Bostjancic John J.

Disclosed activity across 3 companies

Tapewire entity: 87368
SEC CIK: 0001644860

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Orthofix Medical Inc.OFIX · Entity 1975	CFO	February 28, 2023	March 02, 2023
Sonendo, Inc.SONX · Entity 9738	Chief Financial Officer	September 17, 2024	September 19, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Orthofix Medical Inc.

Report date February 28, 2023 · Filed March 02, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	99,670	Reported balance After 2023-02-28 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2023-02-28 · Tax withholding · Disposed 3,783 · Balance 99,670 F1: Includes 52,384 unvested restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 52,384 unvested restricted stock units.

Sonendo, Inc.

Report date September 17, 2024 · Filed September 19, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,320,000	Reported balance After 2024-09-17 transaction · row 1 1 source row Row 1 · 2024-09-17 · Grant · Acquired 600,000 · Balance 1,320,000 F1: Represents an award of Restricted Stock Units ("RSUs") granted to the Reporting Person on September 17, 2024 (the "Grant Date"). Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share of Sonendo, Inc. (the "Issuer"). The RSUs will vest 25% on the first anniversary of the grant date and 6.25% at the end of each three-month period thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of Restricted Stock Units ("RSUs") granted to the Reporting Person on September 17, 2024 (the "Grant Date"). Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share of Sonendo, Inc. (the "Issuer"). The RSUs will vest 25% on the first anniversary of the grant date and 6.25% at the end of each three-month period thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

SeaSpine Holdings Corp

Report date January 05, 2023 · Filed January 09, 2023

Section 16 reporting ended · disclosed 2023-01-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2023-01-05 transaction · row 1 1 source row Row 1 · 2023-01-05 · Disposition to issuer · Disposed 102,563 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 42,696 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-01-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-01-05 · Disposition to issuer · Disposed 13,840 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,761 Orthofix restricted stock units. F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-01-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-01-05 · Disposition to issuer · Disposed 51,795 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,562 Orthofix restricted stock units. F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2023-08-01	Direct	Reported balance After 2023-01-05 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-01-05 · Disposition to issuer · Disposed 62,000 · Balance 0 F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 25,810 shares of Orthofix at a price of $37.67 per share. F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.19 · Expires 2024-01-27	Direct	Reported balance After 2023-01-05 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-01-05 · Disposition to issuer · Disposed 64,599 · Balance 0 F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. F9: The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-01-01	Direct	Reported balance After 2023-01-05 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-01-05 · Disposition to issuer · Disposed 17,818 · Balance 0 F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,417 shares of Orthofix at a price of $43.82 per share. F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.01 · Expires 2028-01-01	Direct	Reported balance After 2023-01-05 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2023-01-05 · Disposition to issuer · Disposed 55,746 · Balance 0 F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 23,207 shares of Orthofix at a price of $28.85 per share. F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.93 · Expires 2028-04-23	Direct	Reported balance After 2023-01-05 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2023-01-05 · Disposition to issuer · Disposed 6,089 · Balance 0 F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share. F15: The option fully vested and became exercisable on June 21, 2020.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2029-01-28	Direct	Reported balance After 2023-01-05 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2023-01-05 · Disposition to issuer · Disposed 69,128 · Balance 0 F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 28,777 shares of Orthofix at a price of $40.50 per share. F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.67 · Expires 2030-02-28	Direct	Reported balance After 2023-01-05 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2023-01-05 · Disposition to issuer · Disposed 43,163 · Balance 0 F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,968 shares of Orthofix at a price of $30.44 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2030-02-28	Direct	Reported balance After 2023-01-05 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2023-01-05 · Disposition to issuer · Disposed 21,704 · Balance 0 F21: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 42,696 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.

F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.

F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.

F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,761 Orthofix restricted stock units.

F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.

F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,562 Orthofix restricted stock units.

F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 25,810 shares of Orthofix at a price of $37.67 per share.

F9: The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.

F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.

F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,417 shares of Orthofix at a price of $43.82 per share.

F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 23,207 shares of Orthofix at a price of $28.85 per share.

F15: The option fully vested and became exercisable on June 21, 2020.

F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share.

F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 28,777 shares of Orthofix at a price of $40.50 per share.

F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,968 shares of Orthofix at a price of $30.44 per share.

F21: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 17, 2024 Filed Sep 19, 2024 21:46 UTC	Sonendo, Inc. SONX · Entity 9738	GrantCommon Stock	600,000	$0.00	$0.00	Disclosure SEC source: 0000950170-24-108215 · ownership.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,320,000 F1 · kind: Represents an award of Restricted Stock Units ("RSUs") granted to the Reporting Person on September 17, 2024 (the "Grant Date"). Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share of Sonendo, Inc. (the "Issuer"). The RSUs will vest 25% on the first anniversary of the grant date and 6.25% at the end of each three-month period thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates. Read SEC document
June 05, 2024 Filed Jun 6, 2024 16:29 UTC	Sonendo, Inc. SONX · Entity 9738	GrantCommon Stock	720,000	$0.00	$0.00	Disclosure SEC source: 0000950170-24-069750 · ownership.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720,000 F1 · shares: Represents an award of Restricted Stock Units ("RSUs") granted to the Reporting Person as a material inducement to employment. Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share of Sonendo, Inc. (the "Issuer"). The RSUs will vest 25% on the grant date anniversary over a 4-year period, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting dates. Read SEC document
February 28, 2023 Filed Mar 2, 2023 21:33 UTC	Orthofix Medical Inc. OFIX · Entity 1975	Tax withholdingCommon Stock	3,783	$30.60	$115,759.80	Disclosure SEC source: 0001209191-23-014703 · doc4.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,670 F1 · balance_after: Includes 52,384 unvested restricted stock units. Read SEC document
January 30, 2023 Filed Feb 1, 2023 23:54 UTC	Orthofix Medical Inc. OFIX · Entity 1975	Tax withholdingCommon Stock	1,694	$21.22	$35,946.68	Disclosure SEC source: 0001209191-23-006005 · doc4.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,453 F1 · balance_after: Includes 59,571 unvested restricted stock units. Read SEC document
January 05, 2023 Filed Jan 9, 2023 23:52 UTC	Orthofix Medical Inc. OFIX · Entity 1975	GrantEmployee Stock Option (Right to Buy) · Derivative	84,566	$0.00 Strike: $20.90	$0.00	Disclosure SEC source: 0001209191-23-002646 · doc4.xml · derivative · entry 2 Bostjancic John J. · CIK 0001644860 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,566 Underlying: Common Stock · 84,566 shares Expires 2033-01-05 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. Read SEC document
January 05, 2023 Filed Jan 9, 2023 23:52 UTC	Orthofix Medical Inc. OFIX · Entity 1975	GrantCommon Stock	35,128	$0.00	$0.00	Disclosure SEC source: 0001209191-23-002646 · doc4.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,147 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. F2 · balance_after: Includes 62,451 unvested restricted stock units. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	21,704	Not disclosed Strike: $15.00	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 11 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,704 shares Expires 2030-02-28 F21 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share. F19 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	43,163	Not disclosed Strike: $12.67	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 10 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,163 shares Expires 2030-02-28 F20 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 17,968 shares of Orthofix at a price of $30.44 per share. F19 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	69,128	Not disclosed Strike: $16.86	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 9 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 69,128 shares Expires 2029-01-28 F18 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 28,777 shares of Orthofix at a price of $40.50 per share. F17 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	6,089	Not disclosed Strike: $9.93	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 8 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,089 shares Expires 2028-04-23 F16 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,534 shares of Orthofix at a price of $23.86 per share. F15 · derivative.exercise_date: The option fully vested and became exercisable on June 21, 2020. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	55,746	Not disclosed Strike: $12.01	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 7 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,746 shares Expires 2028-01-01 F14 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 23,207 shares of Orthofix at a price of $28.85 per share. F13 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	17,818	Not disclosed Strike: $18.24	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 6 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,818 shares Expires 2027-01-01 F12 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,417 shares of Orthofix at a price of $43.82 per share. F11 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	64,599	Not disclosed Strike: $14.19	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 5 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,599 shares Expires 2024-01-27 F10 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. F9 · derivative.exercise_date: The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	62,000	Not disclosed Strike: $15.68	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 4 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,000 shares Expires 2023-08-01 F8 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 25,810 shares of Orthofix at a price of $37.67 per share. F7 · derivative.exercise_date: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerRestricted Stock Units · Derivative	51,795	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,795 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F6 · price: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,562 Orthofix restricted stock units. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerRestricted Stock Units · Derivative	13,840	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · derivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,840 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4 · price: These restricted stock units were assumed by Orthofix in the merger and replaced by 5,761 Orthofix restricted stock units. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document
January 05, 2023 Filed Jan 9, 2023 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Disposition to issuerCommon Stock	102,563	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000032 · wf-form4_167330977776644.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 42,696 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. Read SEC document
January 01, 2023 Filed Jan 3, 2023 17:23 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	5,575	$0.00	$0.00	Disclosure SEC source: 0001637761-23-000009 · wf-form4_167278456660797.xml · derivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 16,724 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022, and 2023. F3 · derivative.expiration_date: The reporting person was granted 16,724 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022, and 2023. Read SEC document
January 01, 2023 Filed Jan 3, 2023 17:23 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	3,281	$8.35	$27,396.35	Disclosure SEC source: 0001637761-23-000009 · wf-form4_167278456660797.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,563 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2023. No shares were sold in connection with this transaction. Read SEC document
January 01, 2023 Filed Jan 3, 2023 17:23 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	5,575	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-23-000009 · wf-form4_167278456660797.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
February 28, 2022 Filed Mar 2, 2022 20:37 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	21,704	$0.00 Strike: $15.00	$0.00	Disclosure SEC source: 0001637761-22-000043 · wf-form4_164627142806192.xml · derivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,704 Underlying: Common Stock · 21,704 shares Expires 2030-02-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
February 28, 2022 Filed Mar 2, 2022 20:37 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	43,163	$0.00 Strike: $12.67	$0.00	Disclosure SEC source: 0001637761-22-000043 · wf-form4_164627142806192.xml · derivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,163 Underlying: Common Stock · 43,163 shares Expires 2030-02-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
February 28, 2022 Filed Mar 2, 2022 20:37 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantRestricted Stock Units · Derivative	51,795	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000043 · wf-form4_164627142806192.xml · derivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,795 Underlying: Common Stock · 51,795 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. Read SEC document
January 28, 2022 Filed Feb 1, 2022 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	6,919	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000026 · wf-form4_164376098940146.xml · derivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,840 Underlying: Common Stock · 6,919 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 20,759 restricted stock units on January 28, 2021, which vest in three equal installments on each of January 28, 2022, 2023 and 2024. F3 · derivative.expiration_date: The reporting person was granted 20,759 restricted stock units on January 28, 2021, which vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document
January 28, 2022 Filed Feb 1, 2022 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	3,628	$11.39	$41,322.92	Disclosure SEC source: 0001637761-22-000026 · wf-form4_164376098940146.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,269 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 28, 2022. No shares were sold in connection with this transaction. Read SEC document
January 28, 2022 Filed Feb 1, 2022 19:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	6,919	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-22-000026 · wf-form4_164376098940146.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:21 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	5,575	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000009 · wf-form4_164134925120476.xml · derivative · entry 5 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,575 Underlying: Common Stock · 5,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The reporting person was granted 16,724 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. F4 · derivative.expiration_date: The reporting person was granted 16,724 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:21 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	5,346	$0.00	$0.00	Disclosure SEC source: 0001637761-22-000009 · wf-form4_164134925120476.xml · derivative · entry 4 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,346 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 16,037 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F3 · derivative.expiration_date: The reporting person was granted 16,037 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:21 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	6,440	$13.62	$87,712.80	Disclosure SEC source: 0001637761-22-000009 · wf-form4_164134925120476.xml · nonDerivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,978 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2022. No shares were sold in connection with this transaction. Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:21 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	5,575	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-22-000009 · wf-form4_164134925120476.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:21 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	5,346	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-22-000009 · wf-form4_164134925120476.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 28, 2021 Filed Jan 29, 2021 17:27 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	69,128	$0.00 Strike: $16.86	$0.00	Disclosure SEC source: 0001637761-21-000033 · wf-form4_161195925257266.xml · derivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,128 Underlying: Common Stock · 69,128 shares Expires 2029-01-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 28, 2021 Filed Jan 29, 2021 17:27 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantRestricted Stock Units · Derivative	20,759	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000033 · wf-form4_161195925257266.xml · derivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,759 Underlying: Common Stock · 20,759 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	5,574	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · derivative · entry 7 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,150 Underlying: Common Stock · 5,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 16,724 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. F5 · derivative.expiration_date: The reporting person was granted 16,724 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	5,346	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · derivative · entry 6 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,346 Underlying: Common Stock · 5,346 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The reporting person was granted 16,037 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F4 · derivative.expiration_date: The reporting person was granted 16,037 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	12,551	$0.00	$0.00	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · derivative · entry 5 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020, and 2021. F3 · derivative.expiration_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020, and 2021. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	12,851	$17.45	$224,249.95	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · nonDerivative · entry 4 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,497 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2021. No shares were sold in connection with this transaction. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	5,574	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · nonDerivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	5,346	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:14 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	12,551	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-21-000017 · wf-form4_160988124448114.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
April 23, 2020 Filed Apr 24, 2020 16:21 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	6,089	$0.00 Strike: $9.93	$0.00	Disclosure SEC source: 0001637761-20-000038 · wf-form4_158775969551010.xml · derivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,089 Underlying: Common Stock · 6,089 shares Expires 2028-04-23 F1 · derivative.exercise_date: The option will fully vest and become exercisable on June 21, 2020, subject to the Reporting Person's continued service to the issuer. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantEmployee Stock Option (Right to Buy) · Derivative	55,746	$0.00 Strike: $12.01	$0.00	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · derivative · entry 9 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,746 Underlying: Common Stock · 55,746 shares Expires 2028-01-01 F7 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	GrantRestricted Stock Units · Derivative	16,724	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · derivative · entry 8 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,724 Underlying: Common Stock · 16,724 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2021, 2022 and 2023. F6 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2021, 2022 and 2023. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	5,345	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · derivative · entry 7 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,692 Underlying: Common Stock · 5,345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 16,037 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F5 · derivative.expiration_date: The reporting person was granted 16,037 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	12,550	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · derivative · entry 6 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,551 Underlying: Common Stock · 12,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020, and 2021. F4 · derivative.expiration_date: The reporting person was granted 37,651 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020, and 2021. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionRestricted Stock Units · Derivative	15,574	$0.00	$0.00	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · derivative · entry 5 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019, and 2020. F3 · derivative.expiration_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019, and 2020. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Tax withholdingCommon Stock	18,286	$12.01	$219,614.86	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · nonDerivative · entry 4 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,877 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2020. No shares were sold in connection with this transaction. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	5,345	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · nonDerivative · entry 3 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	12,550	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · nonDerivative · entry 2 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document
January 01, 2020 Filed Jan 2, 2020 21:16 UTC	SeaSpine Holdings Corp SPNE · Entity 120832	Exercise / conversionCommon Stock	15,574	Not disclosed	Not disclosed	Disclosure SEC source: 0001637761-20-000008 · wf-form4_157801778208442.xml · nonDerivative · entry 1 Bostjancic John J. · CIK 0001644860 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.